Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

C. Marcela Díaz‐Montero(Medical University of South Carolina), Mohamed L. Salem(MUSC Hollings Cancer Center), Michael I. Nishimura(MUSC Hollings Cancer Center), Elizabeth Garrett‐Mayer(MUSC Hollings Cancer Center), David J. Cole(MUSC Hollings Cancer Center), Alberto J. Montero(MUSC Hollings Cancer Center)

Cancer Immunology Immunotherapy

April 29, 2008

10.1007/s00262-008-0523-4

Cited by 1,206

Abstract

Related Papers

No related papers found

Powered by citation graph analysis